InChI=1S/C73H142O17P2/c1- 5- 9- 13- 17- 21- 25- 29- 33- 37- 41- 45- 49- 53- 57- 70(75) 83- 63- 68(89- 72(77) 59- 55- 51- 47- 43- 39- 35- 31- 27- 23- 19- 15- 11- 7- 3) 65- 87- 91(79,80) 85- 61- 67(74) 62- 86- 92(81,82) 88- 66- 69(90- 73(78) 60- 56- 52- 48- 44- 40- 36- 32- 28- 24- 20- 16- 12- 8- 4) 64- 84- 71(76) 58- 54- 50- 46- 42- 38- 34- 30- 26- 22- 18- 14- 10- 6- 2/h67- 69,74H,5- 66H2,1- 4H3,(H,79,80) (H,81,82) /t68- ,69- /m1/s1 |
GRTNLBQYBYZCCM-ULKDXPJMSA-N |
[C@H] (OC(CCCCCCCCCCCCCCC) =O) (COP(OCC(COP(OC[C@H] (OC(CCCCCCCCCCCCCCC) =O) COC(CCCCCCCCCCCCCCC) =O) (O) =O) O) (O) =O) COC(CCCCCCCCCCCCCCC) =O |
|
Mycoplasma genitalium
(NCBI:txid2097)
|
See:
PubMed
|
Mycoplasma genitalium metabolite
Any bacterial metabolite produced during a metabolic reaction in Mycoplasma genitalium.
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
(via cardiolipin )
(via phosphatidylglycerol )
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via cardiolipin )
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via cardiolipin )
(via phosphatidylglycerol )
|
|
View more via ChEBI Ontology
(19R,31R)- 22,25,28- trihydroxy- 16,22,28,34- tetraoxo- 17,21,23,27,29,33- hexaoxa- 22λ5,28λ5- diphosphanonatetracontane- 19,31- diyl dihexadecanoate
|
1',3'-bis[1,2-bis(hexadecanoyl)-sn-glycero-3-phospho]-sn-glycerol
|
1,1',2,2'-tetrahexadecanoyl cardiolipin
|
ChEBI
|
1,1',2,2'-tetrapalmitoyl cardiolipin
|
ChEBI
|
cardiolipin (tetrahexadecanoyl, n-C16:0)
|
MetaCyc
|
Cardiolipin(16:0/16:0/16:0/16:0)
|
HMDB
|
Cardiolipin(64:0)
|
HMDB
|
CL(1'-[16:0/16:0],3'-[16:0/16:0])
|
HMDB
|
CL(16:0/16:0/16:0/16:0)
|
HMDB
|
CL(64:0)
|
HMDB
|
tetrapalmitoyl cardiolipin
|
ChEBI
|
2321326
|
Reaxys Registry Number
|
Reaxys
|
22817898
|
PubMed citation
|
Europe PMC
|
|